Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Barbara Guinn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells
Collin, J. F., Wells, J. W., Czepulkowski, B., Lyne, L., Duriez, P. J., Banham, A. H., Mufti, G. J. & Guinn, B. A., 1 Jan 2015, In: Genes Chromosomes and Cancer. 54, 5, p. 288-302 15 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Application of the pMHC array to characterise tumour antigen specific T cell populations in leukaemia patients at disease diagnosis
Brooks, S. E., Bonney, S. A., Lee, C., Publicover, A., Khan, G., Smits, E. L., Sigurdardottir, D., Arno, M., Li, D., Mills, K. I., Pulford, K., Banham, A. H., Van Tendeloo, V., Mufti, G. J., Rammensee, H. G., Elliott, T. J., Orchard, K. H. & Guinn, B. A., 22 Oct 2015, In: PL o S One . 10, 10, e0140483.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus) -
An analogue peptide from the cancer/testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide
Hardwick, N., Buchan, S., Ingram, W., Khan, G., Vittes, G., Rice, J., Pulford, K., Mufti, G., Stevenson, F. & Guinn, B., 2013, In: Cancer immunity. 13, 3Research output: Contribution to journal › Article › peer-review
14 Citations (Scopus) -
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia
Smits, E. L. J., Lee, C., Hardwick, N., Brooks, S., Van Tendeloo, V. F. I., Orchard, K. & Guinn, B.-A., Jun 2011, In: Cancer Immunology, Immunotherapy. 60, 6, p. 757 - 769 13 p.Research output: Contribution to journal › Literature review › peer-review
22 Citations (Scopus) -
Development of a novel DNA vaccine encorporating a PASD1 analogue peptide which can enhance anti-leukaemia T cell responses in vitro and in vivo
Hardwick, N. R., Buchan, S., Ingram, W., Rice, J., Mufti, G. J., Stevenson, F. K. & Guinn, B. A., 2010, In: British Journal of Haematology. 149, p. 73 - 73 1 p.Research output: Contribution to journal › Meeting abstract
Projects
- 11 Finished
-
Examination of the induction of anti-tumour immue repsonses against PASD1 using modified peptides and the newly developed CASAC adjuvant
Noble, A. (Primary Investigator) & Guinn, B. (Co-Investigator)
1/04/2008 → 30/09/2009
Project: Research
-
Assessment of simultaneous T cell immune responses in acute myeloid leukaemia patients
Guinn, B. (Primary Investigator) & Mufti, G. (Primary Investigator)
1/03/2007 → 28/02/2010
Project: Research
-
Start Up Award
Guinn, B. (Primary Investigator)
British Society for Haematology
1/02/2007 → 31/01/2008
Project: Research
-
Pre-clinical studies of Leukaemia-specific targets for the immunology of AML
Guinn, B. (Primary Investigator) & Mufti, G. (Primary Investigator)
1/02/2005 → 31/10/2008
Project: Research
-
Characterisation of two novel leukaemia specific antigens, PASD1 and SSX2IP, as targets for AML immunotherapy
Guinn, B. (Primary Investigator) & Mufti, G. (Primary Investigator)
1/01/2005 → 31/10/2006
Project: Research